Home › Discount

Discount Market Research Reports : Special Offers & Rates

Our ‘Discounted Reports’ section lists all market research reports, by leading publishers, available at discount rates. We are continuously adding to this list of reports available at discounted prices. This list will keep growing & changing to help you, our customers, leverage your budget wisely. Keep yourself updated with the latest special offers and discounts available on market research reports by visiting this section regularly.

Sort By :
Title Published Discount Original Price Discounted Price

Therapeutic Class Overview : Psoriasis – Plaque Psoriasis & Psoriatic Arthritis : Novel Oral drugs and Biologics to Change Future Treatment Paradigm


Over the last decades, therapeutic options for Plaque Psoriasis (PsO) and Psoriatic Arthritis (PsA) have expanded considerably and improved patients’ pain, function, and quality of life. Approved biologics fill in a critical unmet need...

February 2014 10 % $ 2500 $ 2250.00

Innovative Drug Delivery Systems Opportunities for Generic & Specialty Pharmaceutical companies


There are more than 1400 sustained or controlled release drugs have been approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contri...

February 2014 10 % $ 2500 $ 2250.00

Therapeutic Class Overview: Treating Refractory Hematological Malignancies


Targeting unmet needs in the treatment of cancer/ hematological malignancies through innovative drug development strategies have witnessed favorable outcomes. Over the past decade, Proteasome inhibitor, Velcade (bortezomib) and the immunomod...

February 2014 10 % $ 2500 $ 2250.00

Therapeutic Class Overview : Emergence Of Biogenerics Era In Japan - It's Time to Welcome Antibody Biosimilars of Foreign Origins Soon


With three products and eight players already in market – Japan biosimilar market will enter new phase of biosimilars with first ‘mab’ approval expected in 2014. This approval (Remicade- FY03/13A sales ¥73.5, infiximab ...

February 2014 10 % $ 2500 $ 2250.00

Therapeutic Class Overview: Newer Oral Anti Androgens – Expanding Role in the treatment Paradigm of Prostate Cancer


XTANDI (Enzalutamide) – Does it have potential to compete against ARN-509 in earlier setting?Zytiga (Abiraterone Acetate) – Ongoing Combination trials creates potential beyond Patent Expiry<...

February 2014 10 % $ 2500 $ 2250.00

Therapeutic Class Overview : New Avatars Of Microbes Super Bugs A Growing Threat Worldwide


Novel approaches to treat infection is growing as the need is urgent! Misuse/overuse of antibiotics accelerated antimicrobial resistance (AMR) and has resulted in the emergence of super bugs” which are posing life threatening challeng...

February 2014 10 % $ 1500 $ 1350.00

Global Pharmaceutical and Biotechnology Outlook 2014 :Rising Stars


Innovations have contributed to the availability of a range of new treatments for diseases resulting in improvement in the length and quality of life and reduced disease burden for individuals and society. However, the need for innovative th...

January 2014 10 % $ 2500 $ 2250.00

Global Pharmaceutical and Biotechnology Outlook 2014 - India Pharma


Indian companies are taking center stage in Complex Generics at US and EU markets. In Bio-similars, Indian companies will have perhaps the largest basket aimed at Emerging Countries in 2014-16 and later for Developed countries. Though few bu...

January 2014 10 % $ 2500 $ 2250.00

Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma


2014 will be marked as a transition year for the Japanese Pharma industry - the year is bound to be painful both for innovators and generic companies due to the new regulations. We find these regulations to be 'decisive' in spurring ...

January 2014 10 % $ 2500 $ 2250.00

Global Pharmaceutical & Biotechnology Outlook 2014: Major US and EU


Strategy Diversification Divested: Productivity measurements, Divestment of non-core assets resulting in healthy Cash position- Will accelerate Next wave of targeted acquisitionIn the recent years several new therapies have...

January 2014 10 % $ 2500 $ 2250.00

Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech


Positive sentiments for the biotech sector have prevailed in the last two to three years, and we expect this trend to continue for the next year too. Our optimism is based on the continuity in the flow of innovative products from their pipel...

January 2014 10 % $ 2500 $ 2250.00

2013 French Hospital Cancer Diagnostics Market


This new report from Venture Planning Group contains 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital cancer diagnostics market, including: Major issues pertaining to the French hospit...

December 2012 20 % $ 3850 $ 3080.00

2013 Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies


This report provided sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for 100 chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, calibrators and controls. A...

December 2012 20 % $ 29400 $ 23520.00

2013 Drugs of Abuse Testing Market: US, Europe, Japan


This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major Europ...

December 2012 20 % $ 7500 $ 6000.00

2013 France Clinical Chemistry and Immunodiagnostics Markets


This presents a comprehensive analysis of the French clinical chemistry and immunodiagnostics markets, including:Major issues pertaining to the French clinical chemistry and immunodiagnostic laboratory practice, as well as key economic...

December 2012 20 % $ 5400 $ 4320.00

2013 Germany Clinical Chemistry and Immunodiagnostics Markets


This report presents a comprehensive analysis of the German clinical chemistry and immunodiagnostics markets, including:Major issues pertaining to the German clinical chemistry and immunodiagnostic laboratory practice, as well as key e...

December 2012 20 % $ 5400 $ 4320.00

2013 Italy Clinical Chemistry and Immunodiagnostics Markets


This report presents a comprehensive analysis of the Italian clinical chemistry and immunodiagnostics markets, including:Major issues pertaining to the Italian clinical chemistry and immunodiagnostic laboratory practice, as well as key...

December 2012 20 % $ 5400 $ 4320.00

2013 Japan Clinical Chemistry and Immunodiagnostics Markets


This report presents a comprehensive analysis of the Japanese clinical chemistry and immunodiagnostics markets, including:Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic laboratory practice, as well as k...

December 2012 20 % $ 6800 $ 5440.00

2013 Spain Clinical Chemistry and Immunodiagnostics Markets


This report presents a comprehensive analysis of the Spanish clinical chemistry and immunodiagnostics markets, including:Major issues pertaining to the Spanish clinical chemistry and immunodiagnostic laboratory practice, as well as key...

December 2012 20 % $ 5400 $ 4320.00

2013 UK Clinical Chemistry and Immunodiagnostics Markets


This report presents a comprehensive analysis of the UK clinical chemistry and immunodiagnostics markets, including:Major issues pertaining to the UK clinical chemistry and immunodiagnostic laboratory practice, as well as key economic,...

December 2012 20 % $ 5400 $ 4320.00

2013 US Clinical Chemistry and Immunodiagnostics Markets


This report presents a comprehensive analysis of the US clinical chemistry and immunodiagnostics markets, including:Major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic,...

December 2012 20 % $ 10700 $ 8560.00

2013 Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers


This new report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global transfusion diagnostics market during the next ten years, and assist industr...

December 2012 20 % $ 28600 $ 22880.00

2013 Analysis of Transfusion Diagnostic Typing, Grouping and Screening Tests, And Strategic Profiles and Leading Suppliers


This report presents a comprehensive analysis of the clinical significance and market needs for major transfusion diagnostic typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies...

December 2012 20 % $ 3500 $ 2800.00

2013 Analysis of Transfusion Diagnostic Instrumentation And Strategic Profiles of Leading Suppliers


This new report from Venture Planning Group reviews current instrumentation technologies, and compares features of leading transfusion diagnostic automated and semi-automated analyzers.The report also presents strategic assessments of curre...

December 2012 20 % $ 3500 $ 2800.00

2013 France Transfusion Diagnostic Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 430-page market segmentation analysis of the transfusion testing market.Major issues pertaining to the French transfusion testing practice, as well as key economic, regulatory, demograp...

December 2012 20 % $ 5400 $ 4320.00

2013 Germany Transfusion Diagnostic Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 426-page market segmentation analysis of the transfusion testing market.Major issues pertaining to the German transfusion testing practice, as well as key economic, regulatory, demograp...

December 2012 20 % $ 5400 $ 4320.00

2013 Italy Transfusion Diagnostic Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 412-page market segmentation analysis of the transfusion testing market.Major issues pertaining to the Italian transfusion testing practice, as well as key economic, regulatory, demogra...

December 2012 20 % $ 5400 $ 4320.00

2013 Japan Transfusion Diagnostic Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 426-page market segmentation analysis of the transfusion testing market.Major issues pertaining to the Japanese transfusion testing practice, as well as key economic, regulatory, demogr...

December 2012 20 % $ 6800 $ 5440.00

2013 Spain Transfusion Diagnostic Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 425-page market segmentation analysis of the transfusion testing market.Major issues pertaining to the Spanish transfusion testing practice, as well as key economic, regulatory, demogra...

December 2012 20 % $ 5400 $ 4320.00

2013 UK Transfusion Diagnostic Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 422-page market segmentation analysis of the transfusion testing market.Major issues pertaining to the UK transfusion testing practice, as well as key economic, regulatory, demographic,...

December 2012 20 % $ 5400 $ 4320.00

2013 US Transfusion Diagnostic Testing Market; Opportunities and Strategies for Supplier


HighlightsComprehensive 460-pages market segmentation analysis of the US transfusion testing market.Major issues pertaining to the US transfusion testing practice, as well as key economic, regulatory, demograp...

December 2012 20 % $ 8900 $ 7120.00

2013 France Tumor Marker Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 430-page market segmentation analysis of the transfusion testing market.Major issues pertaining to the French transfusion testing practice, as well as key economic, regulatory, demograp...

December 2012 20 % $ 5400 $ 4320.00

2013 Germany Tumor Marker Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 585-page analysis of the German tumor marker testing market.Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and techn...

December 2012 20 % $ 5400 $ 4320.00

2013 Italy Tumor Marker Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 570-page analysis of the Italian tumor marker testing market.Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and tec...

December 2012 20 % $ 5400 $ 4320.00

2013 Japan Tumor Marker Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 590-page analysis of the Japanese tumor marker testing market.Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and t...

December 2012 20 % $ 6700 $ 5360.00

2013 Spain Tumor Marker Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 565-page analysis of the Spanish tumor marker testing market.Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and tec...

December 2012 20 % $ 5400 $ 4320.00

2013 UK Tumor Marker Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 575-page analysis of the UK tumor marker testing market.Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technol...

December 2012 20 % $ 5400 $ 4320.00

2013 US Tumor Marker Testing Market: Opportunities and Strategies for Supplier


HighlightsComprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological...

December 2012 20 % $ 8700 $ 6960.00

2013 Coagulation Testing Market: US, Europe, Japan - Emerging Business Opportunities and Market Expansion Strategies for Suppliers


This report provides forecasts for 40 major procedures, as well as sales and market shares for reagent and instrument suppliers by country.Available by country and section.This comprehensive seven-country report is d...

December 2012 20 % $ 28700 $ 22960.00

2013 European Coagulation Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies


This unique report provides information not available from any other published source, including test and sales forecasts by market segment, as well as major reagent and instrument suppliers sales and market shares.This comprehensive five-c...

December 2012 20 % $ 18500 $ 14800.00

2013 APTT Testing Market: US, Europe, Japan Test Volume Forecasts by Country and Market Segment through 2018


This report presents a detailed analysis of the APTT testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts b...

December 2012 20 % $ 3850 $ 3080.00

2013 Alpha-2 Antiplasmin Testing Market: US, Europe, Japan Test Volume Forecasts by Country and Market Segment through 2018


This report presents a detailed analysis of the Alpha-2 Antiplasmin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test vol...

December 2012 20 % $ 3850 $ 3080.00

2013 Antithrombin III Testing Market: US, Europe, Japan Test Volume Forecasts by Country and Market Segment through 2018


This report presents a detailed analysis of the AT III testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts...

December 2012 20 % $ 3850 $ 3080.00

2013 D-Dimer Testing Market: US, Europe, Japan Test Volume Forecasts by Country and Market Segment through 2018


This report presents a detailed analysis of the D-Dimer testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecast...

December 2012 20 % $ 3850 $ 3080.00

2013 Factor Assays: US, Europe, Japan Test Volume Forecasts by Country and Market Segment through 2018


This report presents a detailed analysis of the Factor Assays testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume fo...

December 2012 20 % $ 4750 $ 3800.00

2013 Fibrinogen Testing Market: US, Europe, Japan Test Volume Forecasts by Country and Market Segment through 2018


This report presents a detailed analysis of the Fibrinogen testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forec...

December 2012 20 % $ 3850 $ 3080.00

2013 Global HIV/AIDS Diagnostics Market: Growth Opportuinites and Business Expansion Strategies


This report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are revi...

December 2012 20 % $ 4850 $ 3880.00

2013 Adenovirus Diagnostics Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country


This report presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Adenovirus definition, epidemiology and etiology are reviewed. The repor...

December 2012 20 % $ 3850 $ 3080.00

2013 Aeromonads Diagnostics Market: US, Europe, Japan Test Volume and Sales Forecasts by Country


This report presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed. The repor...

December 2012 20 % $ 3850 $ 3080.00

2013 Campylobacter Diagnostics Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country


This reporot presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Campylobacter definition, epidemiology and etiology are reviewed. Th...

December 2012 20 % $ 3850 $ 3080.00
Live Chat
Live Chat by Comm100